Bio Immunitas

Bio Immunitas is an innovative pharmaceutical company with EIS qualifications, taking the lead in developing a novel therapeutic approach that modulates and stabilizes the immune system, acting as a potent antiviral, anti-inflammatory, and immunomodulatory agent with anti-aging capabilities. The safe and effective human recombinant protein platform (hRPP) therapy has undergone several planning and research phases while adapting to market demands. This platform features a unique multi-level mechanism of action with several key indications.